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Is heart rate variability related to  
baroreceptors or FBN1 mutations?
I have read the article “A marked decrease in 
heart rate variability in Marfan syndrome patients 
with confirmed FBN1 mutations” by Cherkas et 
al. with interest [1]. The authors concluded that 
a marked decrease of heart rate variability (HRV) 
may be an important clinical feature in Marfan 
syndrome (MS) patients with confirmed FBN1 
gene mutations.
We know that aortic root disease, leading to 
aneurysmal dilatation, aortic regurgitation, and 
dissection, is the main cause of morbidity and 
mortality in the MS [2]. Dilatation may also involve 
other segments of the thoracic aorta, the abdominal 
aorta, the root of the pulmonary artery or even the 
carotid and intracranial arteries. On the other hand, 
thoracic aortic aneurysms most often result from 
cystic medial degeneration that leads to weakening 
of the aortic wall, and MS is only one of the causes 
of multifactorial etiologies. The other etiological 
factors are chromosomal and inherited syndromes, 
connective tissue disorders, and inflammatory/in-
fectious disorders [2]. In additon, previous studies 
have shown that pressure misregistration among 
baroreceptor sensor nodes, that is related to 
HRV [3], at different vascular bifurcations can 
precipitate feed-forward dysfunctions that promote 
thrombosis, inflammation, and vasomotor dysregulat-
ion resulting in thoracic aneurysm formation [4, 5]. 
Therefore, we understand that baroreceptor sensor 
dysfunction is not the only cause of decreased HRV, 
but also cause of thoracic aortic aneurysm.
Therefore, I am convinced that if the control 
group consisted of 30 thoracic aortic aneurysm pa-
tients without FBN1 mutations, a marked decrease 
of HRV might be an important clinical feature in 
MS patients with confirmed FBN1 gene mutations.
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